SEARCH OUR PRODUCT CATALOG

BRCA1-NF1 Fusion FISH Probe

The BRCA1-NF1 Fusion FISH Probe is used to confirm a fusion of the BRCA1 and NF1 genes. The fusion of the BRCA1 and NF1 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
BRCA1-NF1-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
BRCA1-NF1-20-RERE 20 (40 μL) 200 μL
BRCA1-NF1-20-REOR 20 (40 μL) 200 μL
BRCA1-NF1-20-REGO 20 (40 μL) 200 μL
BRCA1-NF1-20-REGR 20 (40 μL) 200 μL
BRCA1-NF1-20-REAQ 20 (40 μL) 200 μL
BRCA1-NF1-20-ORRE 20 (40 μL) 200 μL
BRCA1-NF1-20-OROR 20 (40 μL) 200 μL
BRCA1-NF1-20-ORGO 20 (40 μL) 200 μL
BRCA1-NF1-20-ORAQ 20 (40 μL) 200 μL
BRCA1-NF1-20-GORE 20 (40 μL) 200 μL
BRCA1-NF1-20-GOOR 20 (40 μL) 200 μL
BRCA1-NF1-20-GOGO 20 (40 μL) 200 μL
BRCA1-NF1-20-GOGR 20 (40 μL) 200 μL
BRCA1-NF1-20-GOAQ 20 (40 μL) 200 μL
BRCA1-NF1-20-GRRE 20 (40 μL) 200 μL
BRCA1-NF1-20-GROR 20 (40 μL) 200 μL
BRCA1-NF1-20-GRGO 20 (40 μL) 200 μL
BRCA1-NF1-20-GRGR 20 (40 μL) 200 μL
BRCA1-NF1-20-GRAQ 20 (40 μL) 200 μL
BRCA1-NF1-20-AQRE 20 (40 μL) 200 μL
BRCA1-NF1-20-AQOR 20 (40 μL) 200 μL
BRCA1-NF1-20-AQGO 20 (40 μL) 200 μL
BRCA1-NF1-20-AQGR 20 (40 μL) 200 μL
BRCA1-NF1-20-AQAQ 20 (40 μL) 200 μL

BRCA1 Gene Summary

This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2009]

Gene Name: BRCA1, DNA Repair Associated

Chromosome: CHR17: 41196311 -41277500

Locus: 17q21.31

NF1 Gene Summary

This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]

Gene Name: Neurofibromin 1

Chromosome: CHR17: 29421944 -29704695

Locus: 17q11.2

Gene Diseases

The BRCA1 NF1 Fusion has been associated with the following diseases:

Disease Name
Prostate Adenocarcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure

Acral melanomas vary considerably in their molecular, histological, and clinical presentation. In this study, acral melanomas from dorsal, volar, and subungual-interdigital body sites were assessed using several tests, including FISH. Our TERT, CCND1, CDK4, AURKA, CDKN2A, PAK1, PTEN, NF1, and GAB2 probes were used to detect copy number variations in these genes. Genetic profiles were found to be tightly tied to UV exposure.

Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure

Acral melanomas vary considerably in their molecular, histological, and clinical presentation. In this study, acral melanomas from dorsal, volar, and subungual-interdigital body sites were assessed using several tests, including FISH. Our TERT, CCND1, CDK4, AURKA, CDKN2A, PAK1, PTEN, NF1, and GAB2 probes were used to detect copy number variations in these genes. Genetic profiles were found to be tightly tied to UV exposure.